In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to reform payment to clinical laboratories under the Clinical Laboratory Fee Schedule (CLFS). CMS's flawed implementation led to rates that fail to reflect private payer rates as intended, years of payment cuts, and a lack of recognition of rising inflation. Without Congressional action, more…
In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to reform payment to clinical laboratories under the Clinical Laboratory Fee Schedule (CLFS). CMS's flawed implementation led to rates that fail to reflect private payer rates as intended, years of payment cuts, and a lack of recognition of rising inflation. Without Congressional action, more cuts will begin on January 1, 2025. ACLA urges Congress to enact long-term PAMA reform to protect access to quality laboratory diagnostics and services.
-
ACLA Files A Motion for Summary Judgment Against HHS In ACLA v. Azar
Washington, D.C. — Following a favorable decision on a jurisdictional question issued by the U.S. Court of Appeals for the D.C. Circuit, the American Clinical Laboratory Association ... Read More -
ACLA Files Reply Brief Ahead of Oral Arguments in ACLA v. Azar Appeal
HHS’ data collection process under PAMA disregards Congressional intent, jeopardizing lab access for millions of seniors Washington, D.C. – The American Clinical Laboratory Association (ACLA) ... Read More -
ACLA Files Appeal in ACLA v. Azar, Asks U.S. Court of Appeals to Address HHS’s Overreach in Data Reporting
HHS’s continued flawed implementation of PAMA threatens beneficiaries’ access to critical lab services Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) advanced its ... Read More -
ACLA Appellant/Petitioner Brief: American Clinical Laboratory Association v. Alex Azar
-
ACLA Statement on Notice of Appeal in ACLA v. Azar
HHS’s continued reliance on faulty data collection process jeopardizes access to critical lab tests for millions of beneficiaries; ACLA files appeal following District Court decision ... Read More -
ACLA Statement on District Court Opinion in Lawsuit Against HHS
Lawsuit targeted HHS’ unlawful implementation of 2014 Medicare legislation, regulatory guidance that would jeopardize beneficiaries’ access to critical lab services Washington, D.C. – Following the ... Read More -
ACLA PAMA Lawsuit Complaint Against CMS
-
ACLA Motion for Summary Judgment in PAMA Law Suit, ACLA v. Azar
